Le Roux-Villet, Christelle <br/><br/>
Rituximab for patients with refractory mucous membrane pemphigoid.  [electronic resource] 

 -  Archives of dermatology  Jul 2011 
 - 843-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-3652 
<br/><br/><label>Standard No.: </label>10.1001/archdermatol.2011.54  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Agammaglobulinemia--chemically induced<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Murine-Derived--immunology<br/>Autoantibodies--immunology<br/>Cohort Studies<br/>Communicable Diseases--chemically induced<br/>Dapsone--immunology<br/>Dermatologic Agents--immunology<br/>Female<br/>Humans<br/>Immunologic Factors--immunology<br/>Immunosuppressive Agents--adverse effects<br/>Male<br/>Middle Aged<br/>Pemphigoid, Benign Mucous Membrane--drug therapy<br/>Rituximab<br/>Severity of Illness Index<br/>Sulfasalazine--immunology<br/>Treatment Outcome<br/>Young Adult